FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Hospital Morales Meseguer
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (28)
2024
-
The effectiveness of adjustable trans-obturator male system (ATOMS) in radiated patients is reduced: A propensity score-matched analysis
BJUI Compass, Vol. 5, Núm. 4, pp. 506-514
2023
-
Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial
European urology oncology, Vol. 6, Núm. 1, pp. 58-66
-
Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019–2021)
Cancers, Vol. 15, Núm. 6
-
Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study)
Cancer Treatment and Research Communications, Vol. 37
-
Results of Adjustable Trans-Obturator Male System in Patients with Prostate Cancer Treated with Prostatectomy and Radiotherapy: A Multicenter Study
Journal of Clinical Medicine, Vol. 12, Núm. 14
2022
-
ATOMS (Adjustable transobturator male system) is an effective and safe second‐line treatment option for recurrent urinary incontinence after implantation of an advance/advance XP fixed male sling. a multicenter cohort analysis
Journal of Clinical Medicine, Vol. 11, Núm. 1
-
Competency assessment of residents of Intensive Care Medicine through a simulation-based objective structured clinical evaluation (OSCE). A multicenter observational study
Medicina Intensiva, Vol. 46, Núm. 9, pp. 491-500
2021
-
Seghi study: Defining the best surveillance strategy in hodgkin lymphoma after first-line treatment
Cancers, Vol. 13, Núm. 10
2020
-
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study
European Journal of Internal Medicine, Vol. 78, pp. 63-68
-
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292
2019
-
Continuous Positive Airway Pressure Treatment Does not Reduce Uric Acid Levels in OSA Women
Archivos de Bronconeumologia, Vol. 55, Núm. 4, pp. 201-207
-
Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1020-1030
2018
-
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database
Critical Care, Vol. 22, Núm. 1
-
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study
BMC Cancer, Vol. 18, Núm. 1
2017
-
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624
-
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial
Tumor Biology, Vol. 39, Núm. 6
-
Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea
European Respiratory Journal, Vol. 50, Núm. 2
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2016
-
Continuous positive airway pressure improves quality of life in women with obstructive sleep apnea a randomized controlled trial
American Journal of Respiratory and Critical Care Medicine, Vol. 194, Núm. 10, pp. 1286-1294
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1